- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kalvista Pharmaceuticals Inc (KALV)
Kalvista Pharmaceuticals Inc stock price live, this page displays NASDAQ KALV stock exchange data. View the KALV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kalvista Pharmaceuticals Inc real time stock price chart below.
What Is the Kalvista Pharmaceuticals Inc Stock Price Today?
The Kalvista Pharmaceuticals Inc stock price today is 12.41.
What Is the Stock Symbol for Kalvista Pharmaceuticals Inc?
The stock symbol for Kalvista Pharmaceuticals Inc is ""KALV.""
What Stock Exchange Does Kalvista Pharmaceuticals Inc Trade On?
Kalvista Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Kalvista Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Kalvista Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KALV quote. (ISIN: US4834971032)
What Is the Kalvista Pharmaceuticals Inc Stock Price Today?
The Kalvista Pharmaceuticals Inc stock price today is 12.41.
What Is the Stock Symbol for Kalvista Pharmaceuticals Inc?
The stock symbol for Kalvista Pharmaceuticals Inc is ""KALV.""
What Stock Exchange Does Kalvista Pharmaceuticals Inc Trade On?
Kalvista Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Kalvista Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Kalvista Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KALV quote. (ISIN: US4834971032)
NASDAQ
Currency in USD
12.41
-0.25(-1.97%)
Closed·
After Hours
12.65+0.24(+1.93%)
·
Fair Value
An estimate of a Kalvista Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.19
12.81
52 wk Range
7.30
16.32
KALV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
KALV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Kalvista Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.1912.81
52 wk Range
7.3016.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KALV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kalvista Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
31.67
Upside
+155.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Kalvista Pharmaceuticals Inc Company Profile
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company’s product candidate is EKTERLY, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. KalVista Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Compare KALV to Peers and Sector
Metrics to compare | KALV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKALVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.4x | −3.5x | −0.5x | |
PEG Ratio | 0.46 | −0.11 | 0.00 | |
Price/Book | 6.5x | 2.7x | 2.6x | |
Price / LTM Sales | - | 8.9x | 3.3x | |
Upside (Analyst Target) | 141.7% | 205.7% | 43.5% | |
Fair Value Upside | Unlock | 3.5% | 6.8% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.67
(+155.17% Upside)
Earnings
Latest Release
Jul 10, 2025
EPS / Forecast
-0.99 / -0.8489
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Kalvista Pharma Trade On?
Kalvista Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Kalvista Pharma?
The stock symbol for Kalvista Pharma is "KALV."
What Is the Kalvista Pharma Market Cap?
As of today, Kalvista Pharma market cap is 617.55M.
What Is Kalvista Pharma's Earnings Per Share (TTM)?
The Kalvista Pharma EPS (TTM) is -3.69.
When Is the Next Kalvista Pharma Earnings Date?
Kalvista Pharma will release its next earnings report on 03 Dec 2025.
From a Technical Analysis Perspective, Is KALV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kalvista Pharma Stock Split?
Kalvista Pharma has split 1 times.
How Many Employees Does Kalvista Pharma Have?
Kalvista Pharma has 270 employees.
What is the current trading status of Kalvista Pharma (KALV)?
As of 09 Aug 2025, Kalvista Pharma (KALV) is trading at a price of 12.41, with a previous close of 12.66. The stock has fluctuated within a day range of 12.19 to 12.81, while its 52-week range spans from 7.30 to 16.32.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.